People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spear Bio Inc. | — | Biotechnology | Series C | $50.1M | $391.9M | 2024 |
Wen Chan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wen Chan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Singer | 1 | 7 |
| John Wu | 1 | 4 |
| Michael Natan | 1 | 3 |
| Vikram Bajaj | 1 | 3 |
| Peng Yin | 1 | 3 |
| Feng Xuan | 1 | 1 |
| Jerome Clavel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.